CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER (calcium chloride)
Ringer’s Injection helps patients who require a supplemental source of water and electrolytes. It is used for both adult and pediatric populations to maintain proper fluid balance and hydration. This solution provides essential minerals that support various physiological processes, including heart function and nerve conduction.
How CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER Works
This injection works by replenishing essential electrolytes and water to maintain the body's internal environment. Sodium and chloride help regulate fluid distribution and acid-base balance, while potassium and calcium are vital for nerve signaling, muscle contractions, and heart function.
Details
- Status
- Prescription
- First Approved
- 2000-01-28
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER Approval History
What CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER Treats
2 indicationsCALCIUM CHLORIDE 10% IN PLASTIC CONTAINER is approved for 2 conditions since its original approval in 2000. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Water deficiency
- Electrolyte deficiency
Drugs Similar to CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER
3 of 19FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Pfizer's other novel FDA approvals
Other CDER-designated drugs from the same sponsor (2016–2025).
Clinical Trial Registry
7 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT07550413 | 20042026 | Ph 2 | not yet recruiting | Role of Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Section |
| NCT03772990 ICARUS | 21/2019 | Ph 4 | completed | Calcium Administration in Cardiac Surgery |
| NCT05027048 CALBLOC results posted | 62206 MRTG-02-15-2022-Ansari, YIG-2020 | Ph 3 | completed | Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery |
| NCT04153435 COCA results posted | 00002 2019-003387-46 | Ph 2 | completed | Calcium for Out-of-Hospital Cardiac Arrest |
| NCT03867383 results posted | 43076 | Ph 1, Ph 2 | completed | Calcium Chloride for Prevention of Uterine Atony During Cesarean |
| NCT01941914 | AA1310 | Ph 1 | completed | Calcium Electroporation for the Treatment of Keloids |
| NCT00955266 results posted | 2009-P-000052 | Ph 4 | terminated | A Trial of Intravenous Calcium and Myocardial Diastolic Dysfunction During Separation From Cardiopulmonary Bypass |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER FDA Label Details
Indications & Usage
FDA Label (PDF)CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER is indicated for the treatment of Water deficiency; Electrolyte deficiency.
Track CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.